| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.31B | 1.34B | 1.32B | 1.23B | 1.14B |
| Gross Profit | 321.90M | 367.55M | 359.07M | 306.35M | 291.80M |
| EBITDA | 92.62M | 97.61M | 102.91M | 52.11M | 91.02M |
| Net Income | 19.63M | 26.60M | 30.61M | -18.30M | 30.69M |
Balance Sheet | |||||
| Total Assets | 764.30M | 803.75M | 799.20M | 791.51M | 852.64M |
| Cash, Cash Equivalents and Short-Term Investments | 64.08M | 55.41M | 58.36M | 46.01M | 53.23M |
| Total Debt | 270.27M | 309.49M | 311.53M | 346.40M | 288.67M |
| Total Liabilities | 592.87M | 648.20M | 659.37M | 668.13M | 641.24M |
| Stockholders Equity | 173.09M | 157.21M | 141.62M | 124.54M | 211.97M |
Cash Flow | |||||
| Free Cash Flow | 92.81M | 9.97M | 67.19M | -6.96M | 23.37M |
| Operating Cash Flow | 101.85M | 51.62M | 103.79M | 27.63M | 54.32M |
| Investing Cash Flow | -36.21M | -41.65M | -36.60M | -57.88M | -70.83M |
| Financing Cash Flow | -57.62M | -12.86M | -54.68M | 25.94M | 24.66M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
58 Neutral | $466.81M | 28.40 | 11.25% | 2.47% | 4.39% | 61.61% | |
56 Neutral | $466.81M | 28.40 | 11.25% | 2.47% | 4.39% | 61.61% | |
56 Neutral | $118.13M | 0.95 | 13.52% | ― | 13.16% | ― | |
55 Neutral | $49.72M | 3.50 | 4.33% | ― | 16.79% | ― | |
44 Neutral | $26.55M | -0.09 | -142.05% | ― | 7.56% | -344.04% |
Crawford & Company reported on March 2, 2026 that its fourth-quarter 2025 revenues before reimbursements fell 11% year-on-year to $308.5 million, resulting in a net loss of $7.2 million after a prior-year profit, while full-year 2025 revenues dipped 2% to $1.27 billion and GAAP net income declined to $19.6 million. Despite softer top-line performance driven largely by reduced weather-related claims activity versus the hurricane-affected 2024 period, the group posted record annual revenues in its Broadspire and International Operations units, improved adjusted operating earnings and EBITDA, and benefited from margin expansion supported by cost discipline, segment diversification, and a post-quarter reorganization into U.S. and International divisions aimed at sharpening client focus and execution.
North America Loss Adjusting and Platform Solutions both saw revenue pressure in 2025 due to fewer severe storms and lower claims and staff augmentation volumes, though North America Loss Adjusting still expanded its operating margin on better utilization. International Operations delivered record full-year revenues of $438.2 million and higher margins on growth in the U.K., Europe, and Asia, while Broadspire achieved a new annual revenue high of $401.9 million and strengthened profitability on new client programs, increased medical management usage, and lower administrative costs, leaving the company with what management described as a strong balance sheet and solid liquidity going into 2026.
The most recent analyst rating on ($CRD.A) stock is a Buy with a $14.00 price target. To see the full list of analyst forecasts on Crawford & Company A stock, see the CRD.A Stock Forecast page.
On January 21, 2026, Crawford & Company announced that, effective January 1, 2026, it adopted a new global operating structure built around two divisions, U.S. Operations and International Operations, to simplify its organization and sharpen its client-centric focus. As part of this shift, the company promoted Mike Hoberman to CEO of U.S. Operations, moved Canada into International Operations under International CEO Andrew Bart, and appointed Pat Van Bakel as chief commercial & strategy officer, while elevating U.S. leaders Paul Kottler, Lance Malcolm and Jeffrey Sickles to head key domestic business lines—changes aimed at clarifying accountability, speeding decision-making and strengthening Crawford’s competitive position and growth prospects in its largest market and globally.
The most recent analyst rating on ($CRD.A) stock is a Buy with a $14.00 price target. To see the full list of analyst forecasts on Crawford & Company A stock, see the CRD.A Stock Forecast page.
On January 14, 2026, Crawford & Company entered into a new executive employment agreement with Michael J. Hoberman in connection with his promotion to CEO – US Operations, effective January 1, 2026. The agreement outlines a compensation package including a $475,000 annual base salary beginning in 2026, a target annual bonus equal to 57.5% of base salary under the Short Term Incentive Plan, long-term incentive awards targeted at $550,000 for 2026, and a sales incentive payment equal to 0.5% of quarterly billed U.S. service fees for the first 24 months of each sale, signaling a strong performance- and growth-oriented focus for the company’s U.S. leadership structure.
The most recent analyst rating on ($CRD.A) stock is a Buy with a $14.00 price target. To see the full list of analyst forecasts on Crawford & Company A stock, see the CRD.A Stock Forecast page.
On December 2, 2025, Crawford & Company and its subsidiaries amended their Credit Agreement with Bank of America, increasing their credit facility to $500 million. This amendment involves replacing the prior UK borrower, releasing it from obligations, and setting new borrowing sublimits for UK, Canadian, and Australian subsidiaries, with the facility maturing in 2030. The agreement includes financial covenants requiring compliance with leverage and interest coverage ratios, with potential default consequences if not met.
The most recent analyst rating on ($CRD.A) stock is a Hold with a $12.00 price target. To see the full list of analyst forecasts on Crawford & Company A stock, see the CRD.A Stock Forecast page.